<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04972149</url>
  </required_header>
  <id_info>
    <org_study_id>4-2021-0409</org_study_id>
    <nct_id>NCT04972149</nct_id>
  </id_info>
  <brief_title>Cohort Study Comparing Surgeon Stress, Utilization of Surgical Instruments, Surgical Outcomes According to Surgical Approach for Gastrectomy</brief_title>
  <official_title>Cohort Study Comparing Surgeon Stress, Utilization of Surgical Instruments, Surgical Outcomes According to Surgical Approach for Gastrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A new surgical instrument is supposed to allow surgeon to do surgery with better performance.&#xD;
      However, the learning period before getting used to the new instruments is necessary. The&#xD;
      surgeon's stress to overcome the learning effect and the surgical outcome was rarely&#xD;
      assessed. The comparative analysis of surgical outcome, surgeon's stress, and utilization of&#xD;
      instruments for gastrectomy will be performed in prospective cohort study&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Before the surgery, all the eligible patients will be explained regarding the study and&#xD;
      informed consent will be given. During the surgery, the surgeon will wear heart rate&#xD;
      monitoring device to monitor hear rate variability of the surgeon. The surgical procedure&#xD;
      will be recorded. After the surgery, morbidity following surgery will be monitored and&#xD;
      recorded. At 1 month after surgery, additional morbidity will be recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 18, 2021</start_date>
  <completion_date type="Anticipated">July 9, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 9, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>complication</measure>
    <time_frame>1 month after surgery</time_frame>
    <description>One of the most important surgical outcome, complication will be measured at 1 month after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>operative time (min)</measure>
    <time_frame>1 month after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bleeding(ml)</measure>
    <time_frame>1 month after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gas passing(day)</measure>
    <time_frame>1 month after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital stay(day)</measure>
    <time_frame>1 month after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>readmission rate(percent)</measure>
    <time_frame>1 month after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability of surgeon</measure>
    <time_frame>during the operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration for each surgical instruments</measure>
    <time_frame>during the operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of use for each surgical instruments</measure>
    <time_frame>during the operation</time_frame>
  </secondary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Gastric Cancer Patients Undergoing Gastrectomy</condition>
  <arm_group>
    <arm_group_label>LC</arm_group_label>
    <description>laparoscopic surgery using conventional laparoscopic instruments</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LW</arm_group_label>
    <description>Using wristed laparoscopic instruments (Artisential Maryland dissector, Artisential Fenestrated grasper)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RC</arm_group_label>
    <description>Conventional robotic surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RSS</arm_group_label>
    <description>Use of single site system for reduced port robotic surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RSP</arm_group_label>
    <description>Use of da Vinci SP system for reduced port robotic surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RRI</arm_group_label>
    <description>A new surgical robot Revo-i developed by Meerae company in Korea</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with gastric cancer scheduled to undergo gastrectomy in high volume center&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients with gastric cancer scheduled for gastrectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Vulnerable subject (illiterate, pregnant)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyoung-Il Kim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yonsei University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hyoung-Il Kim</last_name>
    <phone>82-2-2228-2095</phone>
    <email>cairus@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Severance Hospital, Yonsei University Health System</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyoung-Il Kim</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Grantcharov PD, Boillat T, Elkabany S, Wac K, Rivas H. Acute mental stress and surgical performance. BJS Open. 2018 Sep 27;3(1):119-125. doi: 10.1002/bjs5.104. eCollection 2019 Feb.</citation>
    <PMID>30734023</PMID>
  </reference>
  <reference>
    <citation>Jeong O, Park YK. Clinicopathological features and surgical treatment of gastric cancer in South Korea: the results of 2009 nationwide survey on surgically treated gastric cancer patients. J Gastric Cancer. 2011 Jun;11(2):69-77. doi: 10.5230/jgc.2011.11.2.69. Epub 2011 Jun 30.</citation>
    <PMID>22076206</PMID>
  </reference>
  <reference>
    <citation>Kim HH, Hyung WJ, Cho GS, Kim MC, Han SU, Kim W, Ryu SW, Lee HJ, Song KY. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg. 2010 Mar;251(3):417-20. doi: 10.1097/SLA.0b013e3181cc8f6b.</citation>
    <PMID>20160637</PMID>
  </reference>
  <reference>
    <citation>Kim YM, Baek SE, Lim JS, Hyung WJ. Clinical application of image-enhanced minimally invasive robotic surgery for gastric cancer: a prospective observational study. J Gastrointest Surg. 2013 Feb;17(2):304-12. doi: 10.1007/s11605-012-2094-0. Epub 2012 Dec 1.</citation>
    <PMID>23207683</PMID>
  </reference>
  <reference>
    <citation>Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc. 1994 Apr;4(2):146-8. Erratum in: Surg Laparosc Endosc. 2013 Oct;23(5):480.</citation>
    <PMID>8180768</PMID>
  </reference>
  <reference>
    <citation>Lee JH, Kim KM, Cheong JH, Noh SH. Current management and future strategies of gastric cancer. Yonsei Med J. 2012 Mar;53(2):248-57. doi: 10.3349/ymj.2012.53.2.248. Review.</citation>
    <PMID>22318810</PMID>
  </reference>
  <reference>
    <citation>Lee S, Kim JK, Kim YN, Jang DS, Kim YM, Son T, Hyung WJ, Kim HI. Safety and feasibility of reduced-port robotic distal gastrectomy for gastric cancer: a phase I/II clinical trial. Surg Endosc. 2017 Oct;31(10):4002-4009. doi: 10.1007/s00464-017-5435-y. Epub 2017 Feb 15.</citation>
    <PMID>28205030</PMID>
  </reference>
  <reference>
    <citation>Liu ZY, Chen QY, Zhong Q, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Zheng HL, Zheng CH, Huang CM, Li P. Is three-dimensional laparoscopic spleen preserving splenic hilar lymphadenectomy for gastric cancer better than that of two-dimensional? Analysis of a prospective clinical research study. Surg Endosc. 2019 Oct;33(10):3425-3435. doi: 10.1007/s00464-018-06640-7. Epub 2019 Feb 26.</citation>
    <PMID>30809728</PMID>
  </reference>
  <reference>
    <citation>Niitsu H, Hirabayashi N, Yoshimitsu M, Mimura T, Taomoto J, Sugiyama Y, Murakami S, Saeki S, Mukaida H, Takiyama W. Using the Objective Structured Assessment of Technical Skills (OSATS) global rating scale to evaluate the skills of surgical trainees in the operating room. Surg Today. 2013 Mar;43(3):271-5. doi: 10.1007/s00595-012-0313-7. Epub 2012 Sep 1.</citation>
    <PMID>22941345</PMID>
  </reference>
  <reference>
    <citation>Pietrabissa A, Sbrana F, Morelli L, Badessi F, Pugliese L, Vinci A, Klersy C, Spinoglio G. Overcoming the challenges of single-incision cholecystectomy with robotic single-site technology. Arch Surg. 2012 Aug;147(8):709-14.</citation>
    <PMID>22508669</PMID>
  </reference>
  <reference>
    <citation>Vizza E, Corrado G, Mancini E, Baiocco E, Patrizi L, Fabrizi L, Colantonio L, Cimino M, Sindico S, Forastiere E. Robotic single-site hysterectomy in low risk endometrial cancer: a pilot study. Ann Surg Oncol. 2013 Aug;20(8):2759-64. doi: 10.1245/s10434-013-2922-9. Epub 2013 Mar 7.</citation>
    <PMID>23468046</PMID>
  </reference>
  <reference>
    <citation>Yang SY, Roh KH, Kim YN, Cho M, Lim SH, Son T, Hyung WJ, Kim HI. Surgical Outcomes After Open, Laparoscopic, and Robotic Gastrectomy for Gastric Cancer. Ann Surg Oncol. 2017 Jul;24(7):1770-1777. doi: 10.1245/s10434-017-5851-1. Epub 2017 Mar 29.</citation>
    <PMID>28357674</PMID>
  </reference>
  <reference>
    <citation>Zeng YK, Yang ZL, Peng JS, Lin HS, Cai L. Laparoscopy-assisted versus open distal gastrectomy for early gastric cancer: evidence from randomized and nonrandomized clinical trials. Ann Surg. 2012 Jul;256(1):39-52. doi: 10.1097/SLA.0b013e3182583e2e. Review.</citation>
    <PMID>22664559</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 4, 2021</study_first_submitted>
  <study_first_submitted_qc>July 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 22, 2021</study_first_posted>
  <last_update_submitted>July 23, 2021</last_update_submitted>
  <last_update_submitted_qc>July 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>surgeon stress</keyword>
  <keyword>instrument</keyword>
  <keyword>outcome</keyword>
  <keyword>complication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

